These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 31743046

  • 1. Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model.
    Sarikaya M, Yazihan N, Daş Evcimen N.
    Can J Physiol Pharmacol; 2020 Apr; 98(4):243-251. PubMed ID: 31743046
    [Abstract] [Full Text] [Related]

  • 2. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells.
    Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK.
    FASEB J; 2003 Feb; 17(2):315-7. PubMed ID: 12490536
    [Abstract] [Full Text] [Related]

  • 3. Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways.
    Zeng KW, Li J, Dong X, Wang YH, Ma ZZ, Jiang Y, Jin HW, Tu PF.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):159-71. PubMed ID: 24021941
    [Abstract] [Full Text] [Related]

  • 4. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.
    Chang KC, Snow A, LaBarbera DV, Petrash JM.
    Chem Biol Interact; 2015 Jun 05; 234():254-60. PubMed ID: 25451566
    [Abstract] [Full Text] [Related]

  • 5. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.
    Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK.
    Diabetes; 2004 Nov 05; 53(11):2910-20. PubMed ID: 15504972
    [Abstract] [Full Text] [Related]

  • 6. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells.
    Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK.
    J Biol Chem; 2002 Aug 30; 277(35):32063-70. PubMed ID: 12063254
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells.
    Ramana KV, Bhatnagar A, Srivastava SK.
    FASEB J; 2004 Aug 30; 18(11):1209-18. PubMed ID: 15284221
    [Abstract] [Full Text] [Related]

  • 8. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells.
    Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK.
    Diabetes; 2005 Mar 30; 54(3):818-29. PubMed ID: 15734861
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.
    Pladzyk A, Reddy AB, Yadav UC, Tammali R, Ramana KV, Srivastava SK.
    Invest Ophthalmol Vis Sci; 2006 Dec 30; 47(12):5395-403. PubMed ID: 17122129
    [Abstract] [Full Text] [Related]

  • 10. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition.
    Ramana KV, Willis MS, White MD, Horton JW, DiMaio JM, Srivastava D, Bhatnagar A, Srivastava SK.
    Circulation; 2006 Oct 24; 114(17):1838-46. PubMed ID: 17030682
    [Abstract] [Full Text] [Related]

  • 11. Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition.
    Yadav UC, Srivastava SK, Ramana KV.
    J Diabetes Complications; 2012 Oct 24; 26(5):369-77. PubMed ID: 22658411
    [Abstract] [Full Text] [Related]

  • 12. Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.
    Park J, Kim H, Park SY, Lim SW, Kim YS, Lee DH, Roh GS, Kim HJ, Kang SS, Cho GJ, Jeong BY, Kwon HM, Choi WS.
    Exp Eye Res; 2014 May 24; 122():13-9. PubMed ID: 24631337
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways.
    Song XM, Yu Q, Dong X, Yang HO, Zeng KW, Li J, Tu PF.
    Int Immunopharmacol; 2017 Sep 24; 50():30-37. PubMed ID: 28623716
    [Abstract] [Full Text] [Related]

  • 14. Aldose reductase mediates the mitogenic signals of cytokines.
    Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK.
    Chem Biol Interact; 2003 Feb 01; 143-144():587-96. PubMed ID: 12604244
    [Abstract] [Full Text] [Related]

  • 15. Osmotic expression of aldose reductase in retinal pigment epithelial cells: involvement of NFAT5.
    Winges A, Garcia TB, Prager P, Wiedemann P, Kohen L, Bringmann A, Hollborn M.
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec 01; 254(12):2387-2400. PubMed ID: 27628063
    [Abstract] [Full Text] [Related]

  • 16. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG, Kador PF.
    Curr Pharm Biotechnol; 2011 Mar 01; 12(3):373-85. PubMed ID: 20939801
    [Abstract] [Full Text] [Related]

  • 17. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
    Srivastava SK, Ramana KV, Bhatnagar A.
    Endocr Rev; 2005 May 01; 26(3):380-92. PubMed ID: 15814847
    [Abstract] [Full Text] [Related]

  • 18. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
    Huang Q, Liu Q, Ouyang D.
    Med Chem; 2019 May 01; 15(1):3-7. PubMed ID: 29792152
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway.
    Pal PB, Sonowal H, Shukla K, Srivastava SK, Ramana KV.
    J Mol Endocrinol; 2019 Jul 01; 63(1):11-25. PubMed ID: 30986766
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
    Sampath C, Sang S, Ahmedna M.
    Biomed Pharmacother; 2016 Dec 01; 84():502-513. PubMed ID: 27685794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.